Home Healthcare Biotechnology Oncology Companion Diagnostics Market

Oncology Companion Diagnostics Market Size, Share & Trends Analysis Report By Product and Service (Product, Equipment, Reagents and Consumables, Software/Analysis Tools, Service), By Technology (PCR, ISH, Immunohistochemistry, Sequencing, Microarrays, Imaging Technologies, Other Technologies), By Tumor Type (Benign Tumor, Malignant Tumor), By Type (Next Generation Cancer Diagnostics, Oncology Companion Diagnostics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Jay Mehta | Format: | Report Code: SR4615DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Oncology Companion Diagnostics Market, By Product and Service 2022-2034 (USD MILLION/ Units)
    1. Product
    2. Equipment 
    3. Reagents and Consumables
    4. Software/Analysis Tools
    5. Service
  2. Oncology Companion Diagnostics Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. PCR
    2. ISH
    3. Immunohistochemistry
    4. Sequencing
    5. Microarrays
    6. Imaging Technologies
    7. Other Technologies
  3. Oncology Companion Diagnostics Market, By Tumor Type 2022-2034 (USD MILLION/ Units)
    1. Benign Tumor
    2. Malignant Tumor
  4. Oncology Companion Diagnostics Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Next Generation Cancer Diagnostics
    2. Oncology Companion Diagnostics
  5. Regional Oncology Companion Diagnostics Market
    1. North America
      1. North America Oncology Companion Diagnostics Market By Product and Service 2022-2034 (USD MILLION/ Units)
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
      2. North America Oncology Companion Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. PCR
        2. ISH
        3. Immunohistochemistry
        4. Sequencing
        5. Microarrays
        6. Imaging Technologies
        7. Other Technologies
      3. North America Oncology Companion Diagnostics Market By Tumor Type 2022-2034 (USD MILLION/ Units)
        1. Benign Tumor
        2. Malignant Tumor
      4. North America Oncology Companion Diagnostics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Next Generation Cancer Diagnostics
        2. Oncology Companion Diagnostics
      5. U.S.
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      6. Canada
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
    2. Europe
      1. Europe Oncology Companion Diagnostics Market By Product and Service 2022-2034 (USD MILLION/ Units)
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
      2. Europe Oncology Companion Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. PCR
        2. ISH
        3. Immunohistochemistry
        4. Sequencing
        5. Microarrays
        6. Imaging Technologies
        7. Other Technologies
      3. Europe Oncology Companion Diagnostics Market By Tumor Type 2022-2034 (USD MILLION/ Units)
        1. Benign Tumor
        2. Malignant Tumor
      4. Europe Oncology Companion Diagnostics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Next Generation Cancer Diagnostics
        2. Oncology Companion Diagnostics
      5. U.K.
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      6. Germany
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      7. France
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      8. Spain
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      9. Italy
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      10. Russia
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      11. Nordic
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      12. Benelux
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      13. Rest of Europe
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
    3. APAC
      1. APAC Oncology Companion Diagnostics Market By Product and Service 2022-2034 (USD MILLION/ Units)
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
      2. APAC Oncology Companion Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. PCR
        2. ISH
        3. Immunohistochemistry
        4. Sequencing
        5. Microarrays
        6. Imaging Technologies
        7. Other Technologies
      3. APAC Oncology Companion Diagnostics Market By Tumor Type 2022-2034 (USD MILLION/ Units)
        1. Benign Tumor
        2. Malignant Tumor
      4. APAC Oncology Companion Diagnostics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Next Generation Cancer Diagnostics
        2. Oncology Companion Diagnostics
      5. China
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      6. Korea
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      7. Japan
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      8. India
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      9. Australia
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      10. Taiwan
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      11. South East Asia
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      12. Rest of Asia-Pacific
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
    4. Middle East and Africa
      1. Middle East and Africa Oncology Companion Diagnostics Market By Product and Service 2022-2034 (USD MILLION/ Units)
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
      2. Middle East and Africa Oncology Companion Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. PCR
        2. ISH
        3. Immunohistochemistry
        4. Sequencing
        5. Microarrays
        6. Imaging Technologies
        7. Other Technologies
      3. Middle East and Africa Oncology Companion Diagnostics Market By Tumor Type 2022-2034 (USD MILLION/ Units)
        1. Benign Tumor
        2. Malignant Tumor
      4. Middle East and Africa Oncology Companion Diagnostics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Next Generation Cancer Diagnostics
        2. Oncology Companion Diagnostics
      5. UAE
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      6. Turkey
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      7. Saudi Arabia
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      8. South Africa
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      9. Egypt
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      10. Nigeria
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      11. Rest of MEA
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
    5. LATAM
      1. LATAM Oncology Companion Diagnostics Market By Product and Service 2022-2034 (USD MILLION/ Units)
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
      2. LATAM Oncology Companion Diagnostics Market By Technology 2022-2034 (USD MILLION/ Units)
        1. PCR
        2. ISH
        3. Immunohistochemistry
        4. Sequencing
        5. Microarrays
        6. Imaging Technologies
        7. Other Technologies
      3. LATAM Oncology Companion Diagnostics Market By Tumor Type 2022-2034 (USD MILLION/ Units)
        1. Benign Tumor
        2. Malignant Tumor
      4. LATAM Oncology Companion Diagnostics Market By Type 2022-2034 (USD MILLION/ Units)
        1. Next Generation Cancer Diagnostics
        2. Oncology Companion Diagnostics
      5. Brazil
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      6. Mexico
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      7. Argentina
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      8. Chile
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      9. Colombia
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
      10. Rest of LATAM
        1. Product
        2. Equipment 
        3. Reagents and Consumables
        4. Software/Analysis Tools
        5. Service
        6. PCR
        7. ISH
        8. Immunohistochemistry
        9. Sequencing
        10. Microarrays
        11. Imaging Technologies
        12. Other Technologies
        13. Benign Tumor
        14. Malignant Tumor
        15. Next Generation Cancer Diagnostics
        16. Oncology Companion Diagnostics
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.